The core competencies of our scientific team lie in the understanding of the link mechanisms between pathogens and the specific immune response often associated to the clinical symptoms.

We aim at identifying new biomarkers, of clinical interest and developing relevant assays to measure their presence, thus significantly improving disease diagnosis in patients, prognosis of disease evolution over time and assessment of drug efficacy.

InfYnity Biomarkers’ scientific expertise, technical capabilities and clinical access make it a unique partner for investigating and diagnosing various infectious diseases and opening new ways for treatment.